EpiPro, a Novel, Synthetic, Activity-Regulated Promoter That Targets Hyperactive Neurons in Epilepsy for Gene Therapy Applications is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of Virginia School of Medicine Pilot
Grant: NS090843
University of Virginia School of Medicine Pilot
Grant: NS097726
University of Virginia School of Medicine Pilot
Grant: NS075157
NINDS NIH HHS
Grant: R21 NS090843
NINDS NIH HHS
Grant: R01 NS103090
NINDS NIH HHS
Grant: R56 NS097726
NINDS NIH HHS
Grant: R01 NS075157
NINDS NIH HHS
Grant: R01 NS120702
NINDS NIH HHS
Grant: R01 NS122834
NINDS NIH HHS
Grant: R01 NS097726
National Institutes of Health
Grant: 5R01NS097726-02
Developing a drug-inducible gene therapy for temporal lobe epilepsy
National Institutes of Health
Grant: 5R01NS075157-04
Sodium channels and neuronal excitability in chronic limbic epilepsy.
National Institutes of Health
Grant: 1R21NS090843-01A1
Probing epileptic circuits with novel Cre- and drug-regulated genetic approaches
FWCI
0.11
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals